Spironolactone in patients with heart failure and preserved ejection fraction

被引：4
|
作者：
Nunez, J. [1 ]
Nunez, E. [1 ]
Sanchis, J. [1 ]
机构：
[1] Univ Valencia, INCLIVA, Hosp Clin Univ, Serv Cardiol, Valencia, Spain
来源：
REVISTA CLINICA ESPANOLA | 2016年 / 216卷 / 02期
关键词：
HOSPITALIZATIONS;
D O I：
10.1016/j.rce.2015.10.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [1] Spironolactone in patients with heart failure and preserved ejection fraction
    Sanchez-Sanchez, C.
    Mendoza-Ruiz de Zuazu, H. F.
    Formiga, F.
    Manzano, L.
    Ceresuela, L. M.
    Carrera-Izquierdo, M.
    Gonzalez Franco, A.
    Epelde-Gonzalo, F.
    Cerqueiro-Gonzalez, J. M.
    Montero-Perez-Barquero, M.
    [J]. REVISTA CLINICA ESPANOLA, 2015, 215 (06): : 301 - 307
  • [2] Spironolactone for Heart Failure with Preserved Ejection Fraction
    Dalzell, Jonathan R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (02): : 179 - 179
  • [3] Spironolactone for Heart Failure with Preserved Ejection Fraction
    Pitt, Bertram
    Pfeffer, Marc A.
    Assmann, Susan F.
    Boineau, Robin
    Anand, Inder S.
    Claggett, Brian
    Clausell, Nadine
    Desai, Akshay S.
    Diaz, Rafael
    Fleg, Jerome L.
    Gordeev, Ivan
    Harty, Brian
    Heitner, John F.
    Kenwood, Christopher T.
    Lewis, Eldrin F.
    O'Meara, Eileen
    Probstfield, Jeffrey L.
    Shaburishvili, Tamaz
    Shah, Sanjiv J.
    Solomon, Scott D.
    Sweitzer, Nancy K.
    Yang, Song
    McKinlay, Sonja M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (15): : 1383 - 1392
  • [4] Reply to "Spironolactone in patients with heart failure and preserved ejection fraction"
    Sanchez-Sanchez, C.
    Martin-Casado, M.
    Formiga, F.
    Montero-Perez-Barquero, M.
    [J]. REVISTA CLINICA ESPANOLA, 2016, 216 (02): : 112 - 112
  • [5] Spironolactone, fibrosis and heart failure with preserved ejection fraction
    Reddy, Yogesh N. V.
    Sundaram, Varun
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (09) : 1569 - 1572
  • [6] Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
    Solomon, Scott D.
    Claggett, Brian
    Lewis, Eldrin F.
    Desai, Akshay
    Anand, Inder
    Sweitzer, Nancy K.
    O'Meara, Eileen
    Shah, Sanjiv J.
    McKinlay, Sonja
    Fleg, Jerome L.
    Sopko, George
    Pitt, Bertram
    Pfeffer, Marc A.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (05) : 455 - 462
  • [7] Utilization of spironolactone in patients with reduced or preserved ejection fraction heart failure
    Adimadhyam, Sruthi
    Cosgrove, Austin
    Her, Qoua L.
    Lyons, Jennifer
    Eworuke, Efe
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 229 - 230
  • [8] Prognostic impact of spironolactone in patients with heart failure with preserved ejection fraction
    Antunes, H. Hugo
    Gil, J.
    Goncalves, M. L.
    Abreu, L.
    Marmelo, B.
    Pires, I.
    Moreira, D.
    Almeida, I.
    Correia, M.
    Cabral, C.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 154 - 155
  • [9] Effect of Obesity on Response to Spironolactone in Patients With Heart Failure With Preserved Ejection Fraction
    Elkholey, Khaled
    Papadimitriou, Lampros
    Butler, Javed
    Thadani, Udho
    Stavrakis, Stavros
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2021, 146 : 36 - 47
  • [10] Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function
    Beldhuis, Iris E.
    Myhre, Peder L.
    Bristow, Michael
    Claggett, Brian
    Damman, Kevin
    Fang, James C.
    Fleg, Jerome L.
    McKinlay, Sonja
    Lewis, Eldrin F.
    O'Meara, Eileen
    Pitt, Bertram
    Shah, Sanjiv J.
    Vardeny, Orly
    Voors, Adriaan A.
    Pfeffer, Marc A.
    Solomon, Scott D.
    Desai, Akshay S.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (09) : 1211 - 1221
12345